Capricor Therapeutics (CAPR) EBITDA (2006 - 2026)
Capricor Therapeutics (CAPR) EBITDA from Dec 31, 2006 to Mar 31, 2026. The TTM Capricor Therapeutics (CAPR) EBITDA is -$118M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
Capricor Therapeutics (CAPR) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +111.38% |
| 3 Years TTM | +58.93% |
| 5 Years TTM | +48.04% |
| 10 Years TTM | +24.39% |
| All Time TTM | +30.02% |
Annual EBITDA change of Capricor Therapeutics (CAPR)
| Year | EBITDA | Change |
|---|---|---|
| 2026 | -$36M | -65.89% |
| 2025 | -$106M | +158.26% |
| 2024 | -$41M | +78.79% |
| 2023 | -$23M | -21.09% |
| 2022 | -$29M | +40.94% |
| 2021 | -$21M | +52.69% |
| 2020 | -$14M | +79.23% |
| 2019 | -$7.56M | -50.16% |
| 2018 | -$15M | +19.26% |
| 2017 | -$13M | -24.51% |
| 2016 | -$17M | +34.80% |
| 2015 | -$13M | +109.03% |
| 2014 | -$5.98M | -13.08% |
| 2013 | -$6.88M | +230.77% |
| 2012 | -$2.08M | -57.46% |
| 2011 | -$4.89M | -22.13% |
| 2010 | -$6.28M | -20.20% |
| 2009 | -$7.87M | -40.06% |
| 2008 | -$13M | +27.48% |
| 2007 | -$10M | +299.22% |
| 2006 | -$2.58M | N/A |
Comparison Capricor Therapeutics (CAPR) five years EBITDA CAGR with competitors
Capricor Therapeutics (CAPR) five years EBITDA CAGR is 48.04%.